Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

WEST vs BHST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

WEST Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–2 Matrix Metrics)

WEST Overall Winner 6-Pillar Tally: WEST 4 – 2 BHST Matrix Metrics: WEST 6 – 2 BHST

As of Nov 20, 2026, Westrock Coffee Company (WEST) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WEST carries a Unified Composite Score of 44.7/100 (HOLD) at $7.22 (N/M Forward P/E, -1.2% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. WEST 44.7/100 HOLD), WEST captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-1.2% vs. -18.0% operating margin) and revenue trajectory (-15.4% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: WEST trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 29.2); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WEST vs BHST
WEST NASDAQ Head-to-Head Winner
Westrock Coffee Company Common Stock
Beverages
$7.22
-1.37% 1D
Market Cap $732.5M
TTM Revenue $1.25B
Forward P/E N/M
Beta / 30D Vol 0.56β · 69% Vol
Unified Composite Score
44.7 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 58.0 Mom 55.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 29
RSI-14: 29.2 · SMA20: $8.99 · SMA50: $8.57
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58

6-Pillar Scorecard Institutional Category Breakdown (WEST 4 – 2 BHST)

Columns: Metric · WEST · BHST
1. Valuation Multiples BHST
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 1.0x 0.7x
2. Growth & Scale WEST
Revenue Growth (YoY) -15.4% +3.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $1.25B $35M
Market Cap $732.5M $29.9M
3. Profitability & Quality WEST
Gross Margin 10.9% 59.0%
Operating Margin -1.2% -18.0%
Net Profit Margin -4.4% -31.2%
Return on Equity (ROE) -20.9% -142.5%
4. Balance Sheet & Cash Flow WEST
Cash Generation (TTM) $30M -$9.4M
Cash Flow Margin 2.4% -26.6%
Net Cash / Leverage $523M Net Debt (2.37x D/E) $5.1M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning WEST
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 48.8% (5th %ile) N/A (N/A)
Put/Call OI Skew 3.87x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 12.1% of Rev ($152M) 77.0% of Rev ($27M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WEST (6) vs BHST (2)
Institutional Metric WEST BHST Criterion Row Edge
Market Capitalization
Scale
$732.5M $29.9M Larger Scale WEST
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-15.4% +3.8% Higher Growth BHST
Operating Margin (TTM)
Profitability
-1.2% -18.0% Higher Margin WEST
Net Profit Margin
Profitability
-4.4% -31.2% Higher Margin WEST
Return on Equity (ROE)
Capital Efficiency
-20.9% -142.5% Higher ROE WEST
52-Week Range Position
Momentum
49% ($4–$11) 6% ($1–$7) Stronger Trend WEST
Beta / 30D Volatility
Risk Regime
0.56β · 69% Vol 0.25β · 86% Vol Lower Realized Risk WEST
Unified Institutional Score
Composite Signal
44.7 / 100 (HOLD) 58.2 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$1.25B $35M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
10.9% 59.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.0x EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$30M ($523M Net Debt (2.37x D/E)) -$9.4M ($5.1M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHST +2.87 pp
WEST: -25.49% · BHST: -22.62%
3M Horizon WEST +22.14 pp
WEST: -14.45% · BHST: -36.59%
6M Horizon WEST +52.79 pp
WEST: -13.53% · BHST: -66.32%
1Y Horizon WEST +152.54 pp
WEST: +73.14% · BHST: -79.4%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period WEST Revenue BHST Revenue WEST Op. Margin BHST Op. Margin Margin Leader
FY2020 $550M N/A -21.9% N/A WEST
FY2021 $700M N/A 1.1% N/A WEST
FY2022 $870M N/A 1.0% N/A WEST
FY2023 $860M $10M -2.4% -78.6% WEST
FY2024 $850M $30M -5.8% -27.7% WEST
FY2025 $1.19B $30M -3.8% -16.2% WEST

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WEST CONSOLIDATION
112d in phase · OBV DISTRIBUTION
Current IV 48.8%
IV Percentile 5th %ile
Put/Call OI Skew 3.87x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact WEST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WEST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $732.5M market capitalization and -1.2% operating margin.
OpEx & R&D Reinvestment 12.1% of Rev ($152M)
90D Engineering Disclosures 0 Published
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published

Investor FAQ WEST vs BHST Key Questions & Quantitative Answers

As of Nov 20, 2026, Westrock Coffee Company (WEST) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). WEST carries a Unified Composite Score of 44.7/100 (HOLD) at $7.22 (N/M Forward P/E, -1.2% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. WEST 44.7/100 HOLD), WEST captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-1.2% vs. -18.0% operating margin) and revenue trajectory (-15.4% vs. +3.8% YoY). Technical & Structure Timing Caution: WEST trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 29.2); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

WEST leads the Growth & Scale pillar: WEST posts -15.4% YoY revenue growth and +0.0% YoY earnings growth on $1.25B TTM revenue (10.9% gross margin, -1.2% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). Across the 6-period historical trajectory (FY2020 to FY2025), WEST cumulative revenue shifted +116.4% while BHST shifted +200.0%. In operating R&D and SG&A reinvestment, WEST deploys 12.1% of Rev ($152M) (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.

BHST screens cheaper on headline valuation multiples. WEST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.0x EV/Revenue (2.4% FCF margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WEST (-20.9% ROE) versus BHST (-142.5% ROE) capital efficiency.

In options market volatility and institutional positioning, WEST carries 48.8% implied volatility (5th %ile, Compressed (<25th %ile)), a 3.87x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.56β · 69% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.